Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.540,88
-0,50%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adial Pharmaceuticals Inc (ADIL) Adial Pharmaceuticals Inc (ADIL) Notizie

Adial Pharmaceuticals Inc

ADIL
0,9999
-0,0201 (-1,97%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/11/202422:01EDGAR2Form 8-K - Current report
18/11/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202421:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:30GLOBEAdial Pharmaceuticals Announces Positive Topline Results..
13/11/202422:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202414:30GLOBEAdial Pharmaceuticals Reports Third Quarter 2024 Financial..
12/11/202422:12EDGAR2Form 8-K - Current report
05/11/202414:45EDGAR2Form 8-K - Current report
05/11/202414:30GLOBEAdial Pharmaceuticals Appoints Vinay Shah as Chief Financial..
23/10/202415:00GLOBEAdial Pharmaceuticals to Present at the 2024 ThinkEquity..
17/10/202415:00GLOBEAdial Pharmaceuticals Receives Notice of Allowance for U.S...
15/10/202415:00GLOBEAdial Pharmaceuticals Commends the National Institute on..
28/9/202402:06EDGAR2Form ARS - Annual Report to Security Holders
27/9/202423:20EDGAR2Form DEF 14A - Other definitive proxy statements
19/9/202414:30GLOBEAdial Pharmaceuticals Announces Database Lock in..
04/9/202415:00GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 26th..
14/8/202414:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2024 Financial..
13/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202415:00GLOBEAdial Pharmaceuticals Signs Agreement with Boudicca Dx to..
07/8/202415:00GLOBEAdial Pharmaceuticals Announces Last Patient Dosed in..
31/7/202414:30GLOBEAdial Pharmaceuticals Files New Patent Application to..
23/7/202414:30GLOBEAdial Pharmaceuticals Advances to Second Cohort in..
20/6/202414:30GLOBEAdial Pharmaceuticals Announces Publication in Leading..
05/6/202414:30GLOBEAdial Pharmaceuticals Achieves Important Milestone of First..
29/5/202414:30GLOBEAdial CEO to Present at the Spring MicroCap Rodeo Conference..
15/5/202414:30GLOBEAdial Pharmaceuticals Reports First Quarter 2024 Financial..
14/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/4/202414:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
10/4/202414:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
02/4/202414:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
02/3/202401:00GLOBEAdial Pharmaceuticals Announces Exercise of Warrants for..
28/2/202415:30GLOBEAdial Pharmaceuticals Awarded New Patent from the United..
13/2/202415:15GLOBEAdial Pharmaceuticals Awarded New Patent Notice of Allowance..
25/1/202422:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/1/202422:15EDGAR2Form 8-K - Current report
18/1/202414:30GLOBEAdial Announces Appointment of Tony Goodman as Chief..
16/1/202422:17EDGAR2Form 8-K - Current report
12/1/202422:51EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202315:00GLOBEAdial Pharmaceuticals Receives Final Reimbursement Payment..
12/12/202322:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/12/202317:08EDGAR2Form DEF 14A - Other definitive proxy statements
29/11/202322:47EDGAR2Form 8-K - Current report
29/11/202322:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
28/11/202322:10EDGAR2Form 8-K - Current report
24/11/202315:24EDGAR2Form PRE 14A - Other preliminary proxy statements
Apertura: 1,02 Min: 0,99 Max: 1,02
Chiusura: 1,02

La tua Cronologia

NASDAQ
ADIL
Adial Pharmaceuticals
LSE
0HIY
Atara Biotherapeutics
DOWI
DWMFFN
DJ Middle East & Africa ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network